Author:
Earl John,Kirkpatrick Peter
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference7 articles.
1. Executive summary of the third report of the national cholesterol education program (NCEP) expert on detection, evaluation and treatment of high blood cholesterol (adult treatment panel III). JAMA 285, 2486–2497 (2001).
2. Burnett, D. A., Caplen, M. A., Davis, H. R. Jr, Burrier, R. E. & Clader, J. W. 2-azetidinones as inhibitors of cholesterol absorption. J. Med. Chem. 37, 1733–1736 (1994).
3. Clader, J. W. et al. 2-azetidinone cholesterol absorption inhibitors: structure–activity relationships on the heterocyclic nucleus. J. Med. Chem. 39, 3684–3693 (1996).
4. Van Heek, M. A. et al. In vivo metabolism-based discovery of a potent cholesterol inhibitor, SCH 58235, in the rat and rhesus monkey through identification of the active metabolites of SCH 48461. J. Pharmacol. Exp. Therapeut. 283, 157–163 (1997).
5. Rosenblum, S. B. et al. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-4S-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. J. Med. Chem. 41, 973–980 (1998).
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献